Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pommier

Showing results (61-70 of 251) with videos related to

Pageof 26
Sort By:
Nucleic Acids Research|November 11, 1991
Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposideY Pommier, G Capranico, A Orr, et al.
Journal of the National Cancer Institute|August 17, 1994
Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screenF Leteurtre, G Kohlhagen, K D Paull, et al.
Biochemistry|April 2, 1998
Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigenY Pommier, G Kohlhagen, C Wu, et al.
Medical and Pediatric Oncology|January 1, 1982
High doses of cytosine arabinoside (HD-Ara-C) as reinforcement during remission of acute myeloid leukemiaR Zittoun, J P Marie, Y Pommier, et al.
FEBS Letters|September 15, 2001
Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cellsQ Yu, J H Rose, H Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cellsR Bertrand, P M O'Connor, D Kerrigan, et al.
Journal of Clinical Pathology|April 1, 1986
111 Indium labelling of red cells: its clinical use in haemolytic anaemiasY Najean, Y Pommier, F Deschrywer, et al.
Cancer Research|November 15, 1989
Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cellsC Holm, J M Covey, D Kerrigan, et al.
Molecular Pharmacology|October 1, 1993
Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trialsB Poddevin, J F Riou, F Lavelle, et al.
Annals of the New York Academy of Sciences|December 13, 1996
Cellular resistance to camptothecinsY Pommier, M Gupta, M Valenti, et al.
Pageof 26

Showing results (61-70 of 251) with videos related to

Sort By:
Pageof 26
Nucleic Acids Research|November 11, 1991
Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposideY Pommier, G Capranico, A Orr, et al.
Journal of the National Cancer Institute|August 17, 1994
Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screenF Leteurtre, G Kohlhagen, K D Paull, et al.
Biochemistry|April 2, 1998
Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigenY Pommier, G Kohlhagen, C Wu, et al.
Medical and Pediatric Oncology|January 1, 1982
High doses of cytosine arabinoside (HD-Ara-C) as reinforcement during remission of acute myeloid leukemiaR Zittoun, J P Marie, Y Pommier, et al.
FEBS Letters|September 15, 2001
Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cellsQ Yu, J H Rose, H Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cellsR Bertrand, P M O'Connor, D Kerrigan, et al.
Journal of Clinical Pathology|April 1, 1986
111 Indium labelling of red cells: its clinical use in haemolytic anaemiasY Najean, Y Pommier, F Deschrywer, et al.
Cancer Research|November 15, 1989
Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cellsC Holm, J M Covey, D Kerrigan, et al.
Molecular Pharmacology|October 1, 1993
Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trialsB Poddevin, J F Riou, F Lavelle, et al.
Annals of the New York Academy of Sciences|December 13, 1996
Cellular resistance to camptothecinsY Pommier, M Gupta, M Valenti, et al.
Pageof 26